Literature DB >> 10325384

Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis.

I Pujana1, L Gallego, G Martín, F López, J Canduela, R Cisterna.   

Abstract

PCR fingerprinting was used for the epidemiological investigation of 64 Pseudomonas aeruginosa isolates collected from 16 chronic bronchiectasis patients without cystic fibrosis: 56% of the patients harbored one clone, 12.5% carried a single major type with minor variants, and 31.5% carried two clones. Only a minority of the acquisitions of antibiotic resistance was related to the acquisition of exogenous strains. Mucoid and nonmucoid sets of isolates did not display any consistent differences in their patterns. The genetic similarity among the clones ranged from 10 to 69%. Cross-infection or common-source exposure did not appear to have occurred.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325384      PMCID: PMC85036          DOI: 10.1128/JCM.37.6.2071-2073.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  T Bennekov; H Colding; B Ojeniyi; M W Bentzon; N Høiby
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 2.  Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  M Denton; M H Wilcox
Journal:  J Antimicrob Chemother       Date:  1997-10       Impact factor: 5.790

3.  Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; J Foster; J S Lam; D P Speert
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 4.  Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.

Authors:  V Deretic; M J Schurr; J C Boucher; D W Martin
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

Review 5.  Recent advances in typing of Pseudomonas aeruginosa.

Authors:  C L Poh; C C Yeo
Journal:  J Hosp Infect       Date:  1993-07       Impact factor: 3.926

Review 6.  Prevention of drug access to bacterial targets: permeability barriers and active efflux.

Authors:  H Nikaido
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.

Authors:  U Römling; B Fiedler; J Bosshammer; D Grothues; J Greipel; H von der Hardt; B Tümmler
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

9.  Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.

Authors:  N Masuda; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. The International Pseudomonas aeruginosa Typing Study Group.

Authors: 
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 7.759

View more
  7 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection.

Authors:  Samuel M Moskowitz; Robert K Ernst
Journal:  Subcell Biochem       Date:  2010

3.  Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.

Authors:  María D Maciá; David Blanquer; Bernat Togores; Jaume Sauleda; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis.

Authors:  Taylor E Woo; Jessica Duong; Nicole M Jervis; Harvey R Rabin; Michael D Parkins; Douglas G Storey
Journal:  Microbiology       Date:  2016-12       Impact factor: 2.777

5.  Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

Authors:  Robert K Ernst; Samuel M Moskowitz; Julia C Emerson; Gretchen M Kraig; Kristin N Adams; Megan D Harvey; Bonnie Ramsey; David P Speert; Jane L Burns; Samuel I Miller
Journal:  J Infect Dis       Date:  2007-08-22       Impact factor: 5.226

6.  Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.

Authors:  Mario Anthony; Barbara Rose; Mary Beard Pegler; Mark Elkins; Helen Service; Keerthi Thamotharampillai; Jason Watson; Michael Robinson; Peter Bye; John Merlino; Colin Harbour
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

7.  Genetically Diversity of Pseudomonas aeruginosa Isolated from Chronic Suppurative Otitis Media with Respect to Their Antibiotic Sensitivity Pattern.

Authors:  Mahesh Chandra Sahu; Santosh Kumar Swain; Subrat Kumar Kar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.